Xuefeng Yan

3.0k total citations
46 papers, 2.6k citations indexed

About

Xuefeng Yan is a scholar working on Biomedical Engineering, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Xuefeng Yan has authored 46 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Biomedical Engineering, 15 papers in Molecular Biology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Xuefeng Yan's work include Nanoplatforms for cancer theranostics (17 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Nanoparticle-Based Drug Delivery (6 papers). Xuefeng Yan is often cited by papers focused on Nanoplatforms for cancer theranostics (17 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Nanoparticle-Based Drug Delivery (6 papers). Xuefeng Yan collaborates with scholars based in United States, China and Czechia. Xuefeng Yan's co-authors include Xiaohong Chen, Peng Huang, Orit Jacobson, Gang Niu, Jing Lin, Xiaolian Sun, Hao Hu, Albert J. Jin, Gang Niu and Liang Yu and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Xuefeng Yan

42 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuefeng Yan United States 25 1.6k 826 753 719 339 46 2.6k
Dong‐Eun Lee South Korea 22 1.1k 0.7× 761 0.9× 830 1.1× 712 1.0× 178 0.5× 49 2.4k
Ajlan Al Zaki United States 14 1.1k 0.7× 537 0.7× 595 0.8× 989 1.4× 294 0.9× 17 2.0k
Wenzhi Ren China 36 2.0k 1.3× 1.5k 1.8× 632 0.8× 906 1.3× 289 0.9× 71 3.2k
Huang‐Chiao Huang United States 24 1.5k 1.0× 607 0.7× 690 0.9× 744 1.0× 708 2.1× 64 2.7k
Magdalena Swierczewska United States 22 1.1k 0.7× 500 0.6× 975 1.3× 535 0.7× 131 0.4× 32 2.2k
Wei Deng Australia 28 1.0k 0.6× 711 0.9× 883 1.2× 433 0.6× 335 1.0× 82 2.4k
Wenting Shang China 30 1.3k 0.8× 687 0.8× 566 0.8× 432 0.6× 246 0.7× 55 2.3k
Haibin Shi China 25 1.3k 0.9× 657 0.8× 758 1.0× 384 0.5× 237 0.7× 76 2.2k
Duyang Gao China 36 2.6k 1.7× 1.8k 2.1× 965 1.3× 676 0.9× 501 1.5× 83 3.7k

Countries citing papers authored by Xuefeng Yan

Since Specialization
Citations

This map shows the geographic impact of Xuefeng Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Yan more than expected).

Fields of papers citing papers by Xuefeng Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefeng Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Yan. The network helps show where Xuefeng Yan may publish in the future.

Co-authorship network of co-authors of Xuefeng Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Yan. A scholar is included among the top collaborators of Xuefeng Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Yan. Xuefeng Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Xuefeng, Ping Bai, Jeih-San Liow, et al.. (2025). Syntheses and preclinical evaluations of 11 C-labeled radioligands for imaging brain orexin-1 and orexin-2 receptors with positron emission tomography. RSC Medicinal Chemistry. 16(8). 3787–3798. 1 indexed citations
4.
Yan, Xuefeng, Fabrice G. Siméon, Jeih-San Liow, et al.. (2024). [ 18 F]SF51, a novel 18 F-labeled PET radioligand for translocator protein 18kDa (TSPO) in brain, works well in monkeys but fails in humans. Journal of Cerebral Blood Flow & Metabolism. 45(2). 365–372.
5.
Lerchner, Walter, Paolo Zanotti‐Fregonara, Jeih‐San Liow, et al.. (2024). Evaluation of [18F]fluoroestradiol and ChRERα as a gene expression PET reporter system in rhesus monkey brain. Molecular Therapy. 32(7). 2223–2231.
7.
Yan, Jiahui, Jingwen Zhang, Yanan Wang, et al.. (2023). Rapidly Inhibiting the Inflammatory Cytokine Storms and Restoring Cellular Homeostasis to Alleviate Sepsis by Blocking Pyroptosis and Mitochondrial Apoptosis Pathways. Advanced Science. 10(14). e2207448–e2207448. 58 indexed citations
8.
Yan, Xuefeng, Fabrice G. Siméon, Jeih‐San Liow, et al.. (2023). In vivo evaluation of a novel 18F-labeled PET radioligand for translocator protein 18 kDa (TSPO) in monkey brain. European Journal of Nuclear Medicine and Molecular Imaging. 50(10). 2962–2970. 5 indexed citations
9.
Yan, Jiahui, Yanan Wang, Xinyu Song, et al.. (2022). The Advancement of Gas‐Generating Nanoplatforms in Biomedical Fields: Current Frontiers and Future Perspectives. Small Methods. 6(7). e2200139–e2200139. 30 indexed citations
11.
Siméon, Fabrice G., Jae‐Hoon Lee, Cheryl L. Morse, et al.. (2021). Synthesis and Screening in Mice of Fluorine-Containing PET Radioligands for TSPO: Discovery of a Promising 18F-Labeled Ligand. Journal of Medicinal Chemistry. 64(22). 16731–16745. 17 indexed citations
12.
Zhao, Yi, Jingwen Zhang, Yanan Wang, et al.. (2021). Recent advancements of nanomaterial-based therapeutic strategies toward sepsis: bacterial eradication, anti-inflammation, and immunomodulation. Nanoscale. 13(24). 10726–10747. 28 indexed citations
13.
Wang, Yanan, Chunhui Wang, Keyang Li, et al.. (2021). Recent advances of nanomedicine-based strategies in diabetes and complications management: Diagnostics, monitoring, and therapeutics. Journal of Controlled Release. 330. 618–640. 48 indexed citations
14.
Cheng, Zhen, Xuefeng Yan, Xilin Sun, Baozhong Shen, & Sanjiv S. Gambhir. (2016). Tumor Molecular Imaging with Nanoparticles. Engineering. 2(1). 132–140. 32 indexed citations
15.
Song, Jibin, Xiangyu Yang, Orit Jacobson, et al.. (2015). Biomedical Applications: Ultrasmall Gold Nanorod Vesicles with Enhanced Tumor Accumulation and Fast Excretion from the Body for Cancer Therapy (Adv. Mater. 33/2015). Advanced Materials. 27(33). 4805–4805. 3 indexed citations
16.
Yan, Xuefeng, Gang Niu, Zhe Wang, et al.. (2015). Al[18F]NOTA-T140 Peptide for Noninvasive Visualization of CXCR4 Expression. Molecular Imaging and Biology. 18(1). 135–142. 22 indexed citations
17.
Nie, Liming, Peng Huang, Weitao Li, et al.. (2014). Early-Stage Imaging of Nanocarrier-Enhanced Chemotherapy Response in Living Subjects by Scalable Photoacoustic Microscopy. ACS Nano. 8(12). 12141–12150. 81 indexed citations
18.
Wang, Zhongliang, Zhe Wang, Dingbin Liu, et al.. (2014). Biomimetic RNA‐Silencing Nanocomplexes: Overcoming Multidrug Resistance in Cancer Cells. Angewandte Chemie. 126(7). 2028–2032. 11 indexed citations
19.
Wang, Zhongliang, Zhe Wang, Dingbin Liu, et al.. (2014). Biomimetic RNA‐Silencing Nanocomplexes: Overcoming Multidrug Resistance in Cancer Cells. Angewandte Chemie International Edition. 53(7). 1997–2001. 59 indexed citations
20.
Sun, Xiaolian, Xinglu Huang, Xuefeng Yan, et al.. (2014). Chelator-Free 64Cu-Integrated Gold Nanomaterials for Positron Emission Tomography Imaging Guided Photothermal Cancer Therapy. ACS Nano. 8(8). 8438–8446. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026